Liver mass screening: Difference between revisions
(Created page with "__NOTOC__ {{Liver mass}} {{CMG}} {{AE}}{{MV}} ==Overview== According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routi...") |
m (Bot: Removing from Primary care) |
||
| (5 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Liver mass}} | {{Liver mass}} | ||
{{CMG}} {{AE}}{{MV}} | {{CMG}}; {{AE}}{{MV}} | ||
==Overview== | ==Overview== | ||
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for liver mass. | According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for benign liver mass. However, routine screening is recommended for individuals with [[HBV infection|chronic hepatitis B virus infection]] or [[cirrhosis]] from any cause who are at risk for development of [[Hepatocellular carcinoma|HCC]] by [[ultrasound]] every 6 months. | ||
==Screening== | ==Screening== | ||
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for liver mass.<ref name="US">Recommendations. US preventive services task force(2015) http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=liver+mass Accessed on March, 24th 2016</ref> | According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for benign liver mass. However, routine screening is recommended for individuals with [[HBV infection|chronic hepatitis B virus infection]] or [[cirrhosis]] from any cause who are at risk for development of [[Hepatocellular carcinoma|HCC]] by [[ultrasound]] every 6 months. <ref name="US">Recommendations. US preventive services task force(2015) http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=liver+mass Accessed on March, 24th 2016</ref> | ||
==== Recommended High-Risk Population for Screening for Hepatocellular Carcinoma ==== | |||
* '''Patients with Chronic Hepatitis B Virus Infection (HBsAg positivity)''' | |||
** Asian males over 40 years of age | |||
** Asian females over 50 years of age | |||
** Africans over 20 years of age | |||
** Patients with a family history of [[hepatocellular carcinoma]] | |||
** Patients with high [[Hepatitis B virus|HBV]] viral loads | |||
** Patients with evidence of active [[hepatitis]] | |||
* '''Patients with Cirrhosis of Any Cause''' | |||
** [[Chronic hepatitis B]] | |||
** [[Chronic hepatitis C]] | |||
** [[Alcoholic cirrhosis]] | |||
** [[Non-alcoholic steatohepatitis]] | |||
** [[Hereditary hemochromatosis]] | |||
** [[Autoimmune hepatitis]] | |||
** [[Primary biliary cirrhosis]] | |||
** [[Alpha-1 antitrypsin deficiency]] | |||
==References== | ==References== | ||
{{Reflist| | {{Reflist|2}} | ||
[[Category:Medicine]] | |||
[[Category: | [[Category:Gastroenterology]] | ||
[[Category: | [[Category:Hepatology]] | ||
[[Category:Oncology]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Surgery]] | |||
Latest revision as of 22:32, 29 July 2020
|
Liver Mass Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Liver mass screening On the Web |
|
American Roentgen Ray Society Images of Liver mass screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Overview
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for benign liver mass. However, routine screening is recommended for individuals with chronic hepatitis B virus infection or cirrhosis from any cause who are at risk for development of HCC by ultrasound every 6 months.
Screening
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for benign liver mass. However, routine screening is recommended for individuals with chronic hepatitis B virus infection or cirrhosis from any cause who are at risk for development of HCC by ultrasound every 6 months. [1]
Recommended High-Risk Population for Screening for Hepatocellular Carcinoma
- Patients with Chronic Hepatitis B Virus Infection (HBsAg positivity)
- Asian males over 40 years of age
- Asian females over 50 years of age
- Africans over 20 years of age
- Patients with a family history of hepatocellular carcinoma
- Patients with high HBV viral loads
- Patients with evidence of active hepatitis
- Patients with Cirrhosis of Any Cause
References
- ↑ Recommendations. US preventive services task force(2015) http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=liver+mass Accessed on March, 24th 2016